Pittsburgh Phage Project (P3)

The mission of the Pittsburgh Phage Project (P3) is to form a multi-disciplinary team to conduct phage discovery, determine phage biology and immunogenicity, identify panels of phage specific multidrug resistant organisms (MDRO), establish ethical framework and conduct clinical trials.  The long-term goal will be to develop phage therapy candidates for major MDRO. Hospitals affiliated with the University of Pittsburgh provide advanced tertiary care for high-risk patients with complex conditions; thus, the P3 program is highly relevant. The Pitt environment provides a unique opportunity to leverage our strengths to create a world-class program in phage therapy.

The Pittsburgh Phage Project supported by i4Kids and the Pitt Momentum Funds through Pitt Research and the Office of the Provost.